5PSQ-104 Description of a pharmacovigilance programme in a tertiary hospital

Background and importancePharmacovigilance (PV) is a public health activity in which clinicians are legally and medically involved. Notification of adverse drug reactions (ADRs) is essential to ensure the safety of medications.Aim and objectivesTo describe the ADRs notified to the Regional Centre of...

Full description

Saved in:
Bibliographic Details
Published in:European journal of hospital pharmacy. Science and practice 2020-03, Vol.27 (Suppl 1), p.A197-A198
Main Authors: Muñoz Cejudo, BM, Cantudo Cuenca, MR, Dani Ben Abdel-Lah, L, Mora, MA
Format: Article
Language:English
Subjects:
Age
Conflicts of interest
Drug dosages
Hospitals
Patients
Pharmacy
Prescription drugs
Pulmonary fibrosis
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and importancePharmacovigilance (PV) is a public health activity in which clinicians are legally and medically involved. Notification of adverse drug reactions (ADRs) is essential to ensure the safety of medications.Aim and objectivesTo describe the ADRs notified to the Regional Centre of Pharmacovigilance (RPC).Material and methodsA retrospective study was conducted between January 1992 and December 2018. The hospital pharmacist (HP) was responsible for data collection and notification. PV started up in 1992 accompanied by a strong information and communication campaign. Data were recorded and analysed in Excel 2007: sex and age of patients, total number of reported ADR notifications, detection method, severity and outcome of the ADRs, medications involved and therapeutic group (ATC classification).ResultsDuring the 27 years of the study period, 1246 ADRs were reported (annual average: 46±2.83): 53.6% of patients were men and 54.2% were >65 years old while 10.6% were
ISSN:2047-9956
2047-9964
DOI:10.1136/ejhpharm-2020-eahpconf.421